argenx SE ADS (ARGX)
NGS · Common · CUSIP 04016X101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ARGX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04016X101
Market Cap
Small Cap · $474 Million
IPO
5/18/2017 · $17.00/share
ADR Ratio
1:1
Business: argenx SE is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.

Company Contact

CEO
Tim Van Hauwermeiren
CFO
Eric Castaldi
Investor Relations
Beth DelGiacco, Stern IR · 212-362-1200 · beth@sternir.com
General Email
info@argenx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »